Boosting wound healing in diabetic rats: The role of nicotinamide riboside and resveratrol in UPR modulation and pyroptosis inhibition
International Immunopharmacology · 2024-05 · 132 · 112013
DOI: 10.1016/j.intimp.2024.112013 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-05. Verfasst von Mohammad Hasan Maleki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran; Endocrinology and Metabolism Research Center, Shira…. Hauptthemen laut MEDLINE: Pyroptosis, Wound Healing, Rats, Sprague-Dawley, Resveratrol. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Tehran University of Medical Sciences.
Themen: Wundversorgung
Abstract (Originalsprache)
BACKGROUND: Diabetes-related skin ulcers provide a substantial therapeutic issue, sometimes leading to amputation, needing immediate practical treatments for efficient wound care. While the exact mechanisms are unknown, pyroptosis and deregulation of the unfolded protein response (UPR) are known to exacerbate inflammation. Nicotinamide Riboside (NR) and Resveratrol (RV), which are known for their Nicotinamide adenine dinucleotide (NAD+) boosting and anti-inflammatory properties, are being studied as potential treatments. The purpose of this study was to shed light on the underlying molecular mechanisms and explore the medical application of NR and RV in diabetic wound healing. METHODS: 54 male Sprague-Dawley rats divided into control, diabetic (DM), Gel Base, DM-NR, DM-RV, and DM-NR + RV. Rats were orally administered 50 mg/kg/day of RV and 300 mg/kg/day of NR for 5 weeks. Following diabetes induction, their wounds were topically treated with 5 % NR and RV gel for 15 days. The wound closure rate, body weight, and serum lipid profiles were examined. Gene expression study evaluated UPR and pyroptosis-related genes (BIP, PERK, ATF6, IRE1α, sXBP1, CHOP, NLRP3, caspase-1, NFκB, and IL1-β) in wound tissues, alongside histological assessment of cellular changes. RESULTS: NR and RV treatments greatly enhanced wound healing. Molecular investigation demonstrated UPR and pyroptosis marker modifications, suggesting UPR balance and anti-inflammatory effects. Histological investigation demonstrated decreased inflammation and increased re-epithelialization. The combination of NR and RV therapy had better results than either treatment alone. CONCLUSION: This study shows that NR and RV have therapeutic promise in treating diabetic wounds by addressing UPR dysregulation, and pyroptosis. The combination therapy is a viable strategy to improving the healing process, providing a multimodal intervention for diabetic skin ulcers. These findings pave the way for additional investigation and possible therapeutic applications, giving hope for better outcomes in diabetic wound care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran; Endocrinology and Metabolism Research Center, Shiraz University of Medical Science, Shiraz, Iran.
- Endocrinology and Metabolism Research Center, Shiraz University of Medical Science, Shiraz, Iran.
- Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Student Research Committee, Azerbaijan Medical University, Baku, Azerbaijan.
- Department of Anatomical Sciences, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Trauma Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Molecular Pathology and Cytogenetics Division, Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Ira…
Förderung
- Tehran University of Medical Sciences
Zitieren
APA
Hasan Maleki, M., Siri, M., Jafarabadi, A., Rajabi, M., Amirhossein Mazhari, S., Noori, Z., Koohpeyma, F., Dehghanian, A., Esmaeili, N., Aryanian, Z., & Dastghaib, S. (2024). Boosting wound healing in diabetic rats: The role of nicotinamide riboside and resveratrol in UPR modulation and pyroptosis inhibition. International Immunopharmacology, 132, 112013. https://doi.org/10.1016/j.intimp.2024.112013
Vancouver
Hasan Maleki M, Siri M, Jafarabadi A, Rajabi M, Amirhossein Mazhari S, Noori Z, et al. Boosting wound healing in diabetic rats: The role of nicotinamide riboside and resveratrol in UPR modulation and pyroptosis inhibition. International Immunopharmacology. 2024;132:112013. doi:10.1016/j.intimp.2024.112013
BibTeX
@article{HasanMaleki2024,
author = {Hasan Maleki, Mohammad and Siri, Morvarid and Jafarabadi, Amirhossein and Rajabi, Mahsa and Amirhossein Mazhari, Seyed and Noori, Zahra and Koohpeyma, Farhad and Dehghanian, Amirreza and Esmaeili, Nafiseh and Aryanian, Zeinab and Dastghaib, Sanaz},
title = {Boosting wound healing in diabetic rats: The role of nicotinamide riboside and resveratrol in UPR modulation and pyroptosis inhibition},
journal = {International Immunopharmacology},
year = {2024},
volume = {132},
pages = {112013},
doi = {10.1016/j.intimp.2024.112013}
}
EUVIMED